Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fentanyl Sublingual Spray in Cancer Patients with Mucositis
NCT00956254Phase 3Completed
- Sponsor
- Insys Therapeutics
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough cancer pain (BTcP), sponsored by Insys Therapeutics. Started Oct 2009; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT00956254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956254.